These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39208654)

  • 1. Comprehensive exploration of immune checkpoint-related genes in the prognosis and tumor immune microenvironment of pancreatic adenocarcinoma.
    Chen X; Zhang H
    Clinics (Sao Paulo); 2024; 79():100481. PubMed ID: 39208654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of FAT1 gene in pancreatic adenocarcinoma].
    Liu XY; Yang Y; Yang CD; Ma ZX; Wu CH; Xu C; Zhu R; Liu P; Ying LS; Yin WJ; Su D
    Zhonghua Zhong Liu Za Zhi; 2024 Nov; 46(11):1029-1037. PubMed ID: 39622735
    [No Abstract]   [Full Text] [Related]  

  • 3. CD8 + T-Cell-Related Genes: Deciphering Their Role in the Pancreatic Adenocarcinoma TME and Their Effect on Prognosis.
    Zhang Y; Hou H; Zhang X; Lan H; Huo X; Duan X; Li Y; Zhang X; Zhou N
    Dig Dis Sci; 2024 Nov; ():. PubMed ID: 39604668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel disulfidptosis-related LncRNA prognostic risk model: predicts the prognosis, tumor microenvironment and drug sensitivity in esophageal squamous cell carcinoma.
    Ye C; Xu C; Tang Y; Qi Y; Peng X; Wei G; Jiang L
    BMC Gastroenterol; 2024 Nov; 24(1):437. PubMed ID: 39604874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exploration of key ferroptosis-related genes as therapeutic targets for sepsis based on bioinformatics and the depiction of their immune profiles characterization].
    Li M; Mei Y; Pan A
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Oct; 36(10):1025-1032. PubMed ID: 39586719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes.
    Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P
    J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive pan-cancer analysis of CD73: Explore its association with prognosis and tumor immune microenvironment.
    Chen C; Liu S; Ma Y
    Heliyon; 2024 Nov; 10(22):e40329. PubMed ID: 39624281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Immunological Significance of ANKRD52 in Pan-Cancer.
    Yin HZ; Zhang MC; Wu H
    Biochem Genet; 2024 Dec; 62(6):4335-4358. PubMed ID: 38296907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the prognostic significance of mitophagy-associated genes in multiple myeloma: a novel risk model construction.
    Min R; Hu Z; Zhou Y
    Clin Exp Med; 2024 Oct; 24(1):249. PubMed ID: 39470826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioresistance-related gene signatures identified by transcriptomics characterize the prognosis and immune landscape of pancreatic cancer patients.
    Wang D; Cao J; Chen Y; Zhang L; Zhou C; Huang L; Chen Y
    BMC Cancer; 2024 Dec; 24(1):1497. PubMed ID: 39639217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma.
    Zhan X; Li J; Ding Y; Zhou F; Zeng R; Lei L; Zhang Y; Feng A; Qu Y; Yang Z
    Clin Exp Med; 2024 Jul; 24(1):145. PubMed ID: 38960987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering potential molecular mechanisms in clear cell renal cell carcinoma based on the ubiquitin-conjugating enzyme E2 related genes: Identifying UBE2C correlates to infiltration of regulatory T cells.
    Feng X; Wang Z; Cen M; Zheng Z; Wang B; Zhao Z; Zhong Z; Zou Y; Lv Q; Li S; Huang L; Huang H; Qiu X
    Biofactors; 2024 Nov; ():. PubMed ID: 39614426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC2A3 promotes head and neck squamous cancer developing through negatively regulating CD8
    Jiang W; Xu S; Zhao M; Li C
    Sci Rep; 2024 Nov; 14(1):29458. PubMed ID: 39604419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of Radioresistant-Related Telomere Genes in the prognosis and immune infiltration in lung adenocarcinoma.
    Li P; Meng L; Tu H; Luo S; Gong X
    Cancer Cell Int; 2024 Nov; 24(1):387. PubMed ID: 39580387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines on lung adenocarcinoma prognosis based on immuno-glycolysis-related genes.
    Zhang Y; Qin W; Zhang W; Qin Y; Zhou YL
    Clin Transl Oncol; 2023 Apr; 25(4):959-975. PubMed ID: 36447119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ELF1 combined with MMP9 is associated with prognosis and tumor microenvironment in gastric cancer.
    Zhang X; Ren X; Zhang S; Wang Y
    Exp Ther Med; 2024 Dec; 28(6):441. PubMed ID: 39583246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis and immune landscape of bladder cancer can be predicted using a novel miRNA signature associated with cuproptosis.
    Zhang Z; Liu F; Yu Y; Xie F; Zhu T
    PeerJ; 2024; 12():e18530. PubMed ID: 39624133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p.
    Yi J; Ye Z; Xu H; Zhang H; Cao H; Li X; Wang T; Dong C; Du Y; Dong S; Zhou W
    Phytomedicine; 2024 Dec; 135():156137. PubMed ID: 39566403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune landscape of the tumour microenvironment in Ethiopian breast cancer patients.
    Yohannes M; Desalegn Z; Bauer M; Stückrath K; Anberbir E; Bekuretsion Y; Assefa M; Wakuma T; Worku Y; Santos PSC; Taylor L; Adissie A; Wickenhauser C; Massa C; Vetter M; Kantelhardt EJ; Seliger B; Abebe T
    Breast Cancer Res; 2024 Nov; 26(1):162. PubMed ID: 39587630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.